Become A Wiser, More Profitable Investor

FDA approves non-opioid painkiller designed to eliminate risk of addiction

Health

Journavx, approved for short-term pain, will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids. Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering an alternative to both opioids and over-the-counter medications like ibuprofen and acetaminophen. But the medication’s modest effectiveness and lengthy development process underscore the challenges of finding new ways to manage pain.Studies in ...

Fast Company     Jan 31, 2025